nAMDneovascular age-related macular degenerationfaricimab
…ent outcomes of 186 eyes that underwent IVF for treatment-naïve nAMD or nAMD previously treated except for >3 months before the base…
19articles mentioning diseases
46disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: nAMD ×
nAMD
This disease is selected. Its supporting articles are shown below.
Articles mentioning nAMD
19 articles · page 1 of 2retinal vein occlusionage-related macular degenerationdiabetic macular oedemanAMDRVOneovascular retinal diseasesDMEranibizumab
…macular degeneration (nAMD), diabetic macular oedema (DME), and retinal vein occlusion (RVO). In the last 5 years, new molecules, extended dosing inte…
geographic atrophynAMDneovascular age-related macular degenerationranibizumabavacincaptad pegolACPNCT00709527
…egol (ACP), a Food and Drug Administration-approved therapy for geographic atrophy, administered in combination with ranibizumab, an approved ther…
nAMDneovascular age-related macular degenerationfaricimabBellberry LimitedAnti-vascular endothelial growth factor therapySinghealth Centralized Institutional Review BoardSt Vincent’s Hospital Human Research Ethics Committee
…centre investigator-initiated clinical trial. 102 patients with nAMD meeting inclusion criteria were recruited from 12 clinical site…
nAMDtype I neovascular age-related macular degenerationpolypoidal choroidal vasculopathy (PCV)
… was characterised by decreased CVI and increased MCT, while in nAMD, only MCT and CV increased. Notably, combined CVI decrease and …
nAMDneovascular age-related macular degeneration
…on.Methods Retrospective, observational study. Stable, inactive nAMD patients who had been treated with a treat-and-extend regimen a…
nAMDNeovascular age-related macular degenerationbrolucizumabranibizumabafliberceptfaricimabVerteporfinPubMed
…uating ranibizumab, brolucizumab, aflibercept, and faricimab in nAMD. Baseline characteristics included age, sex, race, best-correct…
neovascular age-related macular degenerationnAMDafliberceptCENTRALEmbase
…aflibercept biosimilars compared with reference aflibercept for neovascular age-related macular degeneration (nAMD).Methods and analysis Systematic review and meta-analysis…
Age-related Macular DegenerationnAMDAMDanti-VEGFGalician Network of Ethics CommitteesSpanish Clinical Studies Registry
…armacoproteomics in the development of personalised medicine in Age-related Macular Degeneration (PHARPRO-AMD) is to find new proteomic biomarkers, predictive o…
neovascular age-related macular degenerationnAMDafliberceptAflibercept biosimilars
…imilars compared with reference aflibercept in the treatment of neovascular age-related macular degeneration (nAMD).Methods A systematic review and meta-analysis were condu…
diabetic macular oedemaneovascular age-related macular degenerationnAMDDMEfaricimabranibizumabafliberceptbrolucizumab
…ment of neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DME). Unlike previous anti-VEGF agents, faricimab targets both…
neovascular age-related macular degenerationnAMDFYB203reference afliberceptEU-approved reference aflibercept
… aflibercept FYB203 with reference aflibercept in patients with neovascular age-related macular degeneration (nAMD).Methods and analysis Patients aged ≥50 years with newly …